Sackley, C.M.Rick, C.Au, P.Brady, M..C.Beaton, G.Burton, C.Caulfield, M.Dickson, S.Dowling, F.Hughes, M.Ives, N.Jowett, S.Masterson-Algar, P.Nicoll, A.Patel, S.Smith, C.H.Woolley, R.Clarke, C.E.2020-06-182020-06-182020-05-27Sackley, C M, Rick, C, Au, P, Brady, M C, Beaton, G, Burton, C, Caulfield, M, Dickson, S, Dowling, F, Hughes, M, Ives, N, Jowett, S, Masterson-Algar, P, Nicoll, A, Patel, S, Smith, C H, Woolley, R & Clarke, C E 2020, 'A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson’s disease : a study protocol for a randomised controlled trial', Trials, vol. 21, no. 1, 436, pp. 436. https://doi.org/10.1186/s13063-020-04354-71745-6215ORCID: /0000-0001-9677-4817/work/74731494https://hdl.handle.net/2164/14522This study is funded by the NIHR HTA programme (HTA: 10/135/02). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. The study design, collection, management, analysis and interpretation of the data, publishing the data is the responsibility of the chief investigator, and the Collaborative Group. The funder does not have any role in the above.13683030engDysarthriaIdiopathic Parkinson's diseaseLee Silverman voice treatmentRandomised controlled trialSpeech and language therapyTREATMENT LSVT(R)INTELLIGIBILITYVALIDATIONPEOPLELOUDNESSSPEAKERSCOMMUNICATIONLIFER MedicinePharmacology (medical)Medicine (miscellaneous)National Institute for Health Research (NIHR)HTA: 10/135/02RJournal article10.1186/s13063-020-04354-7http://www.scopus.com/inward/record.url?scp=85085589368&partnerID=8YFLogxK211